Nanexa AB
556833-0285ActiveNanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Overview
- 10–19
- Employees
- 5–10M SEK
- Revenue
- 2010
- Founded
Key Decision Makers
Anders Johansson
Head of Intellectual Property
David Westberg
Chief Executive Officer
Bridget Lacey
Chief Business Officer
Göran Ando
Chairman of the Board
+15 more contacts in Funnelfeedr
Description
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556833028501
Decision Makers
19 contacts in FunnelfeedrAnders Johansson
Head of Intellectual Property
David Westberg
Chief Executive Officer
Bridget Lacey
Chief Business Officer
Göran Ando
Chairman of the Board
Marie Gårdmark
Director Regulatory Affairs
Cecilia Danckwardt-Lillieström
Chief Financial Officer
Bengt Gustavsson
Board Member
Polla Rouf
Head of R&D ALD
Sven Undeland
Director Strategic Market Analysis
Jonas Fransson
Head of Pharmaceutical Development
Mikael Asp
Head of Quality Assurance, Special Advisor
Jakob Dynnes Hansen
Board Member
Richard Davis
Board Member
Kristine Bäck
Director Project Management
Joel Hellrup
Head of Pharmaceutical R&D
Mårten Rooth
Chief Technology Officer, Co-founder
Hanna Tilus
Board Member
Birgit Stattin Norinder
Board Member
Björn Svanström
current CFO (leaving)
Similar Companies
20 similar companies in Funnelfeedr
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Iconovo AB
10–19 employeesLeading partner developing patented dry powder inhaler drug delivery systems.
Double Bond Pharmaceutical AB
5–9 employeesDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
AcroPharma AB (publ)
0 employeesDeveloping innovative preventive therapeutics for major human diseases.
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
Browse More
Nanexa AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo